Remove Development Remove Pharmaceuticals Remove Productivity Remove Sales
article thumbnail

Drug Pricing in the United States

Tom Spencer

Over the last decade, the money generated by prescription drug companies from sales in the U.S. 1 Pharmaceutical companies are unique in their capacity, due to little regulation and oversight, to raise prices. skyrocketed , growing at average rate of 61%, almost three times faster than increases in sales volumes. has doubled.

article thumbnail

ZS Associates Firm Profile

Management Consulted

Today’s emphasis is on ZS Associates (pronounced Zee S in the USA) – a premier boutique firm focused on sales force and marketing optimization. Upon realizing that their findings were highly applicable to the problems of sales force sizing and resource allocation, they decided to investigate further. sales force teams.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Pharma Playbook for Success in Southeast Asia

BCG

To capture the immense opportunities in emerging markets, pharmaceutical companies require highly targeted strategies. And what works in developed markets won’t necessarily work in emerging economies. By 2020, emerging markets will account for more than 30% of pharmaceutical sales growth worldwide.

article thumbnail

Sales Bonuses Are Supposed to Motivate, So Don’t Waste Them on Easy Targets

Harvard Business

The belief is that at-risk pay motivates salespeople to work hard and direct effort towards sales activities that encourage achievement of sales goals. sales forces, but the mix varies across industries and sales roles. Within an industry or company, pay mix often varies across sales roles.

Sales 28
article thumbnail

Price Gouging and the Dangerous New Breed of Pharma Companies

Harvard Business

For 78-year-old Tony, 3,4 DAP — which can be obtained at low cost from compounding pharmacies or for free through a compassionate-use program supported by a small privately held company, Jacobus Pharmaceuticals — is a lifesaver. Pharmaceutical companies traditionally invest heavily in research and development.

article thumbnail

Fixing Pharma’s Incentives Problem in the Wake of the U.S. Opioid Crisis

Harvard Business

Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. Meanwhile, the amount of prescription opioids sold by pharmaceutical companies has quadrupled, despite no proliferation in the amount of reported pain.

article thumbnail

How Pharma Companies Game the System to Keep Drugs Expensive

Harvard Business

The 1984 Drug Price Competition and Patent Term Restoration Act gave pharmaceutical companies exclusive protections for innovating a new drug. That was the payoff for shouldering the high risk and high costs of developing new drugs. During this time, no other companies can market a generic product.

System 44